People with PAH have less diversity among the viruses that infect bacteria in the digestive tract, according to a study.

A large clinical trial testing a once-daily inhaled treatment for PAH is now recruiting, after data showed long-term benefits ...

High concentrations of a heart-related protein in pregnant women with PAH show those at a high risk of complications after ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Respiratory rehabilitation is safe and can help improve exercise capacity in people with chronic obstructive pulmonary disease (COPD) with or without pulmonary hypertension (PH), a study reported. A ...

Pulmonary hypertension (PH) is a rare but severe condition characterized by high blood pressure that affects pulmonary arteries – the vessels responsible for transporting blood from the heart to the ...

At the Pulmonary Hypertension Association’s (PHA) biannual conference, it is easy to feel like you should be able to do more. There are sessions to attend, people to meet, dinners to join, and ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Winrevair (sotatercept-csrk), an injection therapy approved for ...

A team of scientists in China identified four genes that may serve as potential treatment targets for idiopathic pulmonary arterial hypertension (PAH). “This study combined [computer-based genetic ...

Researchers identified two genes — PRDX1 and TNFAIP3 — whose activity levels could serve as diagnostic biomarkers for idiopathic pulmonary arterial hypertension (PAH). The genes are related to ...

The U.S. Food and Drug Administration (FDA) has extended its tentative approval of Yutrepia, an inhaled dry powder formulation of treprostinil, to pulmonary hypertension associated with interstitial ...